Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Operating Income (2016 - 2025)

Avricore Health has reported Operating Income over the past 11 years, most recently at -$324117.3 for Q4 2025.

  • Quarterly Operating Income fell 595.09% to -$324117.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$996368.8 through Dec 2025, down 1156.33% year-over-year, with the annual reading at -$990174.8 for FY2025, 1150.89% down from the prior year.
  • Operating Income was -$324117.3 for Q4 2025 at Avricore Health, down from -$277279.6 in the prior quarter.
  • Over five years, Operating Income peaked at $117610.1 in Q1 2024 and troughed at -$342079.5 in Q2 2025.
  • The 5-year median for Operating Income is -$46357.7 (2021), against an average of -$90250.2.
  • Year-over-year, Operating Income surged 585.83% in 2023 and then plummeted 965.42% in 2025.
  • A 5-year view of Operating Income shows it stood at -$32138.0 in 2021, then tumbled by 447.19% to -$175856.1 in 2022, then skyrocketed by 128.68% to $50442.8 in 2023, then rose by 29.78% to $65466.6 in 2024, then tumbled by 595.09% to -$324117.3 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Operating Income are -$324117.3 (Q4 2025), -$277279.6 (Q3 2025), and -$342079.5 (Q2 2025).